Psychiatry and Neurology, Neurology · Indianapolis, IN
NPI
1407850068
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8402 Harcourt Rd Ste 615
Indianapolis, IN, 46260
Phone (317) 806-6991
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
1,400 services
Medicare patients, 2024
697
Average age 74
Drug cost, 2024
$1.6M
1,144 prescriptions
Company payments, 2025
$3,329
From 36 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kuimil K Mohan was code 95886 (electrical nerve conductivity), 439 times for 231 patients. In total Kuimil K Mohan billed 1,400 services in 32 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95886 Electrical Nerve Conductivity | Office | 439 | 231 | $69.59 | $31K |
| 99214 Office E&M - Established | Office | 278 | 224 | $84.58 | $24K |
| 95911 Electrical Nerve Conductivity | Office | 90 | 90 | $150.71 | $14K |
| 95816 Neurologic | Facility | 72 | 72 | $40.06 | $2,885 |
| 95913 Electrical Nerve Conductivity | Office | 62 | 62 | $193.57 | $12K |
| 99232 Hospital E&M - Subsequent | Facility | 60 | 45 | $58.25 | $3,495 |
| 95720 Neurologic | Facility | 54 | 33 | $148.70 | $8,030 |
| 99215 Office E&M - Established | Office | 44 | 39 | $132.20 | $5,817 |
| 95912 Electrical Nerve Conductivity | Office | 35 | 35 | $161.91 | $5,667 |
| 99204 Office E&M - New | Office | 30 | 30 | $112.39 | $3,372 |
| 95910 Electrical Nerve Conductivity | Office | 30 | 30 | $129.33 | $3,880 |
| 95816 Neurologic | Office | 28 | 28 | $273.24 | $7,651 |
| 99233 Hospital E&M - Subsequent | Facility | 27 | 25 | $87.63 | $2,366 |
| 95810 Sleep Study | Facility | 22 | 22 | $83.66 | $1,841 |
| 99205 Office E&M - New | Office | 19 | 19 | $149.44 | $2,839 |
By year: 2022 $151K for 1,538 services; 2023 $143K for 1,438 services; 2024 $136K for 1,400 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kuimil K Mohan prescribed most often to Medicare patients was Levetiracetam, with 74 prescriptions and refills. In total Kuimil K Mohan wrote 1,144 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levetiracetam Generic | 74 | 168 | 20 | $3,475 |
| Gabapentin Generic | 61 | 101 | 16 | $901 |
| Levetiracetam Er Levetiracetam | 51 | 144 | 18 | $4,861 |
| Pregabalin Generic | 47 | 77 | Under 11 | $1,553 |
| Emgality Pen Galcanezumab-Gnlm | 46 | 46 | Under 11 | $32K |
| Aimovig Autoinjector Erenumab-Aooe | 45 | 49 | Under 11 | $36K |
| Topiramate Generic | 42 | 84 | Under 11 | $351 |
| Nurtec Odt Rimegepant Sulfate | 41 | 41 | Under 11 | $62K |
| Donepezil Hcl Generic | 39 | 103 | 11 | $417 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 33 | 47 | Under 11 | $2,126 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 27 | 55 | Under 11 | $600 |
| Xyrem Sodium Oxybate | 25 | 25 | Under 11 | $526K |
| Memantine Hcl Generic | 25 | 55 | Under 11 | $900 |
| Horizant Gabapentin Enacarbil | 23 | 23 | Under 11 | $25K |
| Ropinirole Er Ropinirole Hcl | 23 | 37 | Under 11 | $2,803 |
Brand drugs: 337 claims; generic drugs: 796 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kuimil K Mohan $3,329 ($3,329 in general payments such as food, travel and fees) from 36 companies. The largest payer was Vanda Pharmaceuticals Inc. with $351.
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. VNDA | 7 | $351 |
| Abbvie Inc. ABBV | 23 | $338 |
| Harmony Biosciences LLC HRMY | 14 | $321 |
| Jazz Pharmaceuticals Inc. JAZZ | 9 | $303 |
| UCB, Inc. UCB.BR | 11 | $201 |
| Argenx US, Inc. ARGX | 6 | $187 |
| Celgene Corporation BMY | 10 | $175 |
| Amgen Inc. AMGN | 7 | $123 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $118 |
| MDD US Operations, LLC | 6 | $114 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.